Abstract
Recovery of acetylcholinesterase (AChE) at endplates of mouse sternomastoid muscle was studied after inactivation with di-isopropylfluorophosphate in viva. A short incubation with a-bungarotoxin was used to prevent muscle necrosis which usually occurs after esterase inactivation.
Under these conditions there was no delay in AChE recovery, unlike what we had previously seen in necrotic muscle. However, even in non-necrotic muscle, the overall recovery of AChE at the postjunctional membrane was very slow, with a half-life of about 20 days. The fact that, at adult neuromuscular junctions, both esterases and receptors turn over about 10 times slower than they do in embryonic muscle suggests a similar regulation of these two molecules by the nerve.
Several studies have examined turnover of acetylcholinesterase (AChE) in brain (Chippendale et al., 1974; Wenthold et al., 1974; Yaksh et al., 1975; Grubic et al., 1981) and in muscle (Filogamo and Gabella, 1966; lnestrosa and Fernandez, 1977; Wooten and Cheng, 1980 ). Yet, to date, no study had quantitatively examined the turnover of AChE specifically at the postsynaptic region of the neuromuscular junction (NMJ) of uninjured vertebrate muscle. In an earlier study we found that, when the esterases at a mouse NMJ are inactivated, there is a delay of more than 3 days when no recovery of AChE can be seen. Thereafter the inactivated AChE recovers very slowly (t3h > 20 days) (Salpeter et al., 1979) . Esterase inactivation, however, leads to muscle necrosis (Preussen, 1967; Fischer, 1968; Ariens et al., 1969; Fenichel et al., 1972; Laskowski et al., 1977; Hudson et al., 1978; Leonard and Salpeter, 1979; Salpeter et al., 1979 Salpeter et al., , 1982 . We wondered whether this necrosis, which lasts about 7 days under our conditions, could be responsible for either the initial delay or the subsequent slow AChE recovery. The present study therefore re-examined esterase recovery in muscles which were protected from necrosis by inactivation of the junctional acetylcholine receptors (AChRs) with ol-bungarotoxin ((Y-BTX) (Leonard and Salpeter, 1979; Salpeter et al., 1979) .
We found that the initial delay in AChE recovery was indeed prevented in undamaged muscle; however, the recovery rate of AChE at the postjunctional folds was still slow, having an estimated half-life of about 20 days.
Materials and Methods
Animal preparations for inactivating esterases. We used the sternomastoid muscle of the albino mouse (obtained from Blue Spruce Farms). Receptor and esterase inactivation was performed as previously described by Fertuck et al. (1975) Fertuck and Salpeter (1976) and Salpeter et al. (1979) . Animals were anesthetized with Nembutal (50 mg in 10% alcohol/kg of body weight). The muscle was exposed and the nerve was stimulated with a suction electrode while muscle contractions were monitored with a needle electrode attached to an isotonic transducer.
The exposed muscle was first bathed in ol-BTX (lo+ M in Krebs' Ringer Solution) until the receptors were completely inactivated as judged by the fact that the muscle was unable to produce a tetanic contraction (Fertuck et al., 1975) . The esterases were then inactivated by di-isopropylfluorophosphate (DFP) (low3 M) in Krebs' Ringer, pH 7.4, applied topically to the muscle for 1.5 to 2.0 hr. Full esterase inactivation after such an incubation time was previously established (Salpeter et al., 1979) by the elimination of staining for esterases (Karnovsky and Roots, 1964) and by the loss in ability to sustain a tetanic contraction.
After the double inactivation of receptors and esterases, the incision was closed and the animal was allowed to recover. The animals were reanesthetized 1, 3, or 7 days later and were perfused with phosphate-buffered 4% formaldehyde freshly prepared from paraformaldehyde, as described by Karnovsky (1965) . The experimental sternomastoid muscle was cut into several longitudinal pieces and immersion fixed for an additional 3 hr in fresh fixative, then stored in rinse buffer overnight.
Labeling of esterases. Pieces from each muscle were divided into three groups and incubated for labeling by one of the following procedures as previously described (Roqers et al.. 1969) . (7) To label all DFP-reactive sites we usedjH-DFP (10' M-in Krebs' Ringer, 'pH 7.4, 3.3 Ci/mmol) for 1 hr at room temperature.
(2) To label only AChE we used nonradioactive DFP (as above), followed by pyridine 2-aldoxime methiodide (2-PAM) (10m3 M in rinse buffer, pH 7.9) at room temperature for 40 min to reactivate phosphorylated AChE (Wilson et al., 1958; Wilson and Froede, 1971) followed by 3H-DFP (as above). (3) To label all DFP-reactive sites except AChE we used ?-f-DFP (as above) followed by 2-PAM (as above).
After the incubation sequences the tissue pieces were washed three times in rinse buffer (for a total of 15 min), then in several washes of nonradioactive DFP (10T3 M twice for 5 min and low4 M three times for 20 min) to remove nonspecific binding, and then left overnight in buffer.
Autoradiography. Tissue blocks were postfixed in 1% aqueous OsO.,, block stained in 2% uranyl acetate at room temperature, dehydrated, and embedded in Epon 812. Pale gold sections were cut, and their thickness was measured by an interferometer. Sections were then prepared for autoradiography by the "flat substrate" method of Salpeter and Bachmann (1964, 1972 ; for a detailed description of the technique, see also Salpeter, 1981) using a closely packed monolayer of llford L4 emulsion (deep purple to blue interference color). The slides were developed after a suitable time of exposure, calculated to give about 5 grains/end bouton for easy grain counting (28 to 486 days). Endplates in the developed autoradiograms were photographed in Philips 201 or 300 electron microscopes and enlarged in printing to x 20,000. The grain density was obtained by first counting all grains in an area of emulsion expected to be exposed to radiation emanating from a radioactive line source coincident with the postjunctional membrane (PJM) (i.e., 0.5 pm on the axonal side and 2.0 pm on the muscle side of the axonal membrane).
Background grains per unit area of autoradiogram were obtained over muscle at a distance from the junction and subtracted from the grains tabulated over the junction. The endplate grains, after background correction, were then divided by the surface area of the PJM measured in the autoradiograms (length of membrane times the measured thickness of section). This grain density was used to calculate sites per square micrometer of PJM as given in Salpeter et al., 1972 . Vol. 5, No. 4, Apr. 1985 damage is prevented there is no delay in recovery of AChE (and there may in fact be a slight early acceleration of recovery), but the recovery rate itself is not much faster-again extrapolating to a tn of -20 days.
There seems to be an interesting relationship between the turnover of AChEs and AChRs. In noninnervated chick muscles grown in culture, receptors turn over with a half life of -20 hr and some esterases with a half-life of -50 hr (Rotundo and Fambrough, 1980b) . Thus, in noninnervated muscle, esterases turn over -2 to 3 times slower than do receptors. Our current finding indicates that a similar relationship between the turnover time of esterases and receptors prevails at the innervated adult NMJ where the turnover rate of both molecules is slowed to the same extent (about lo-fold). After innervation, junctional receptors have a fy, of 8 to 10 days (Berg and Hall, 1975; Chang and Huang, 1975; Burden, 1977; Heinemann et al., 1978; Reiness et al., 1978; Stanley and Drachmann, 1978; Loring and Salpeter, 1980; Michler and Sakmann, 1980; Levitt and Salpeter, 1981) , and junctional esterases have a f,+ of -20 days (this study). Co-transport of receptors and esterases has been suggested for cultured muscle by Rotundo and Fambrough (1980a) . The dramatic shift to a turnover rate that is -1 O-fold slower at innervated junctions of both molecules suggests a similar regulation of these molecules by the nerve.
Results and Discussion
Figure 1 illustrates an EM autoradiogram from muscle 7 days after inactivation with LU-BTX and nonradioactive DFP in vivo. The morphology of the muscle and endplates and the relative distribution of grains between the PJM and the Schwann cap appear normal. Similar normal morphology was seen at all times after inactivation with DFP due to the saturation of the receptors with a-BTX. Table I gives the recovery of DFP-binding sites per square micrometer of PJM for the three labeling conditions. We found that, on the average, the fraction of total DFP-binding sites that are AChE (2-PAM reactivated) remains relatively constant (approximately one-fourth to onethird) during the recovery period examined. These ratios are similar to those in normal muscle (Rogers et al., 1969; Salpeter, 1969) and are in marked contrast to that seen during recovery in necrotic muscle (Salpeter et al., 1979) , in which only about 6% of all new DFP-binding sites are AChE by day 7.
Figure 2 plots the recovery of the three forms of DFP-binding sites on a semilogarithmic scale (as original sites minus newly labeled sites). Each curve gives a half-life of 220 days.
Many studies have dealt with turnover of esterases (e.g., Davison, 1953; Koenig and Koelle, 1961; lnestrosa and Fernandez, 1977; Koelle et al., 1977a, b; Wooten and Cheng, 1980) . Our study is the first to look quantitatively at the recovery of sites specifically at the PJM of intact NMJs in viva. In an earlier study we found that, after inactivation with DFP, muscles become damaged and have a significant delay (between 3 and 7 days) before any new AChE (2-PAM reactivatable) sites recover. Once recovery begins, however (at about 5 days), there is a recovery curve which extrapolates to a fH of about 20 days. In the present study we see that when muscle
We have used 2-PAM reactivation (Wilson et al., 1958; Rogers et al., 1969) as a way to separate AChE from other DFP-binding sites. In normal muscle we consistently find that 2-PAM reactivates about 30% of the endplate sites (Rogers et al., 1969; Salpeter, 1969; Salpeter et al., 1972) and is the same fraction of sites protected by the specific AChE inhibitor, the Burroughs-Wellcome compound BW 284C51
(1,5-bis[4-allyl-dimethyl-ammonium-phenyl]pentane-3-one dibromide) (Rogers et al., 1969; Rotundo and Fambrough, 1980b) . This emphasizes the fact that our labeling conditions during processing of the tissue successfully avoids the risk of DFP aging which could prevent reactivation with 2-PAM (Berends et al., 1959) . and Methods" after inactivation of all sites with nonradioactive DFP in viva, and the site density of these newly labeled sites was assessed by EM autoradiography.
(Values are derived by combining the values listed separately in Table I .) The semilogarithmic plot was obtained by subtracting the newly labeled sites (at different times after inactivation) from the site density normally present (given as zero time value). Extrapolated curves and halflives were obtained by linear regression assuming that turnover follows firstorder kinetics. The three curves, which were obtained independently, show essentially the same recovery rate for both the AChE and non-AChE sites. This is in marked contrast to the situation reported previously (Salpeter et al., 1979) for muscle not protected from necrosis after esterase inactivation.
In such necrotic muscle non-AChE sites have a much faster initial recovery rate than do AChE sites.
The nature of the DFP-binding sites not reactivated by 2-PAM or protected by BW 284C51 is not known. In the normal mouse muscle only about 10 to 30% of all DFP-binding sites are butyrylcholinesterase (BuChE) (Rogers et al., 1969; Barnard et al., 1971 ; H. Kasprzak and M. M. Salpeter, manuscript in preparation), and the rest (>40%) are of as yet undetermined nature. The rather constant ratio of the different species of DFP-binding sites invites speculation on their functional relationship. After inactivation, these sites recover at the same rate in cultured chick muscle (Rotundo and Fambrough, 1980a ) but at different rates in necrotic muscle (Salpeter et al., 1979 ). The present study shows that, if myopathy is prevented, the ratio of AChE to other DFP-binding sites remains constant during recovery. The delayed AChE synthesis and the uncoupling of its turnover from that of the other DFP-binding sites in damaged muscle are incompatible with the suggestion that BuChE is a precursor molecule for AChE (Koelle et al., 1977a, b; see also Edwards and Brimijoin, 1982) .
The role of muscle in maintenance of junctional AChE is not yet resolved. Although synthesis of AChE by noninnervated muscle has been described (Brzin and Majcen-Tkacev, 1963; Tennyson et al., 1973; Sawyer et al., 1976; Golder et al., 1978; Rotundo and Fambrough 1980a, b; Brockman et al., 1982) , other studies claim that muscle may contribute only a small portion of the junctional AChE compared to axonally transported material (e.g., Wooten and Cheng, 1980) . In our experiments the nerve was left intact in the studies both with and without CI-BTX protection from muscle damage, yet, in the studies in which the muscle was damaged by the esterase inactivation (Salpeter et al., 1979) , there was a delay in AChE recovery of about 3 to 7 days which corresponds to the peak period of damage. This strongly suggests that the muscle is a major contributor to the junctional AChE, although the nerve is clearly important in regulating endplate AChEs (Filogamo and Gabella, 1966; Guth et al., 1966; Guth, 1968; Drachman, 1972; Hall, 1973; Vigny et al., 1976; Koenig and Vigny, 1978; Rubin et al., 1980; Weinberg et al., 1981) , both via induced muscle activity (Giacobini et al., 1973; Rubin et al., 1980; L0mo and Slater, 1978, 1980) and via nerve factors (Guth et al., 1966; Guth, 1969; Lentz, 1972; Oh, 1976; Davey et al., 1979; Fernandez et al., 1979; Younkin et al., 1982) .
As has been cited above, muscle activity may control AChE synthesis, although the extent of this control is not yet fully clarified, especially in adult muscle (e.g., Guth, 1969; Collins and Younkin, 1982) . Therefore, there can be a concern that a-BTX could affect recovery of AChE by eliminating muscle activity. But we only gave one dose of cr-BTX, and the ability to obtain neurally induced muscle contraction recovers to some extent already by 2 days after such an (u-BTX treatment (Fertuck et al., 1975) , even though relatively few of the inactivated AChRs have turned over at that time (-15% by 2 days) (Loring and Salpeter, 1980) . With esterases reduced, muscle activity recovers even more quickly. We therefore assume that muscle inactivity is not the cause for the slow recovery of AChE in the present study. The rapid recovery of some nerve-induced muscle activity may in fact raise the question as to why muscle necrosis does not develop in our a-BTX-pretreated muscle since relatively few esterase molecules have recovered during the first 2 days (-10%). However, an explanation may come from the "saturating disk" model of neuromuscular response formulated in several publications from our laboratory (Fertuck and Salpeter, 1976; MatthewsBellinger and Salpeter, 1978; Salpeter and Land, 1980; Land et al., 1980 Land et al., , 1981 Salpeter, 1983) . According to this model, even if AChR site density is low, muscle response will occur provided each quantum of ACh can spread over a large enough postsynaptic area to activate a sufficiently large number of receptors. The ratio of esterases to receptors then becomes crucial in determining the minimum AChR site density at which muscle contraction will occur. Since the AChEs recover at almost the same rate as do the receptors, a balance of AChE to AChR is maintained over the postsynaptic surface during recovery. This should allow an adequate Vol. 5, No. 4, Apr. 1985 number of receptors to be activated to produce muscle contraction while providing for a sufficiently rapid hydrolysis of the ACh after unbinding. Repeated reactivation of receptors would thus be prevented, eliminating the cause of the necrosis in the absence of esterases (Leonard and Salpeter, 1979) .
It is well known that denervation causes a drastic drop in junctional AChE activity with a half-life of -1 to 2 days and that this drop seems to be under neurotrophic control (Davey and Younkin, 1978; Fernandez et al., 1979; Ranish et al., 1980; Collins and Younkin, 1982) . If, as we claim here, AChEs at innervated NMJs are replaced with a half-life of -20 days, denervation could not cause the drop in junctional AChE merely by turning off AChE synthesis. DeneNation must therefore cause an acceleration of AChE degradation, possibly due to proteolytic enzymes released from degenerating nerve, to which the esterases in the neuromuscular cleft should be very sensitive (Hall and Kelly, 1971; Betz and Sakmann, 1971, 1973; McMahan et al., 1978) . This suggestion is compatible with the finding that a longer distal nerve stump delays both the onset of nerve degeneration (e.g., Lemo, 1976 ) and the rapid drop in postdenervation junctional esterases (Fernandez et al., 1979; Ranish et al., 1980; Collins and Younkin, 1982) .
In conclusion, the data presented here suggest that, normally, the turnover rate of junctional AChE is very slow. We do not know the physiological significance of the fact that, at the innervated NMJ, the turnover rate of esterases is slowed to the same extent as is that of the receptors. It may insure stability and a relatively constant ratio of AChE to AChR, which is very important for maintaining normal neuromuscular function. 
